155A.45  Reports — disclosure.
  1.  Notwithstanding section 272C.6, subsection 4, paragraph “a”, an inspection report in possession of the board, regardless of whether the report is based on a routine inspection or an inspection prompted by one or more complaints, may be disclosed to the national association of boards of pharmacy’s inspection network.
  2.  Notwithstanding section 272C.6, subsection 4, paragraph “a”, any complaints, investigative information, or data collected pertaining to compounded human drug products may be disclosed to the United States food and drug administration, including through the use of an information sharing network, in order to comply with any memorandum of understanding with the United States food and drug administration.
2016 Acts, ch 1093, §8; 2021 Acts, ch 68, §7
Section amended